Clinical trials resume
Trials were ceased after one participant had an adverse reaction to the vaccine. All goody to go again...
Trials were ceased after one participant had an adverse reaction to the vaccine. All goody to go again...
Most Popular
Sponsored
ILMN beats revenue/EPS estimates, lifts guidance. Clinical demand & NovaSeq X drive growth. Buy?
Ube prices surge 38% amid supply chain strain & 20% export growth. Farmers face rising costs, impacting returns.
Hormuz deadlock persists, oil prices soar on supply loss. Recession fears rise as buffers exhaust.
CARR beats revenue/EPS estimates! Data center surge fuels growth, but tariffs bite. Buy now?
AI powers nuclear SMRs! BWXT & RYCEY offer stable returns with 10%+ margins & strong EPS growth.
HSY beats Q1 revenue & EPS estimates! Pricing power drives 10.6% sales growth despite volume dips. Valuation watch.
WIN Advisors bets $13M on HGER ETF, up 40% YTD, for inflation hedge. Yields 5.7%.
Sponsored
Must Read